Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

The blood cancer multiple myeloma, which involves infection-fighting plasma cells in the bone marrow, affects only about 1% of all cancers -- predominantly individuals over age 65. The disease ...

In multiple myeloma, these plasma cells become cancerous, multiplying uncontrollably and interfering with the normal function of the bone marrow and immune system. Although it is a complex disease ...

The findings, which were presented at the 50th Annual Oncology Nursing Society Congress, showed that at a median follow-up of ...

Support grows for a new test designed to monitor individuals at risk of multiple myeloma, aiming for earlier detection and ...

Median time to sustained worsening of symptoms was 23.7 months with cilta-cel ... Patients treated with ide-cel, Abecma for relapsed/refractory multiple myeloma affecting the central nervous system ...

Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), according to a study published online March 25 in the Journal of Clinical ...

he explained in a 2024 update on multiple myeloma. This left physicians in a "catch-22" situation, that sabotaged their efforts to optimize treatment by first requiring the presence of symptoms a ...

Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't ...